目的监测耐甲氧西林金黄色葡萄球菌（MRSA）医院感染现状及耐药性，为临床合理选用抗菌药物提供参考。
To study the present situation of nosocomial infection and drug resistance of Methicillin-resistant Staphylococcus Aureus (MRSA), provide reference for clinical rational use of drugs.
目的分析和总结耐甲氧西林金黄色葡萄球菌（MRSA）肺炎发病的高危因素、临床特点及药物敏感性的分布情况。
Objective To analyze the clinical characteristics of pneumonia caused by methicillin-resistant staphylococcus aureus (MRSA) and to investigate the drug sensitivity of MRSA stains.
临床治疗金黄色葡萄球菌感染，应建立在体外药敏试验的基础上，有针对性地选择抗菌药物。
Clinical treatment for staphylococcus aureus infection should be based on drug sensitivity test in vitro; antibiotics should be chosen with care.
金黄色葡萄球菌的耐药性日趋严重，加强其耐药性的检测，合理使用抗菌药物，可以延缓和避免耐药菌株的出现。
To avoid the occurrence of resistance of S. aureus, it is critically important to monitor the drug resistance of S. aureus and use antibacterial agents rationally.
亚标准包括儿童的皮肤病生活质量指数(CDLQI)，金黄色葡萄球菌在皮肤的分布情况和皮肤的药物治疗情况。
Secondary measures included the Children's Dermatology Life Quality Index (CDLQI), S. aureus skin colonization, and pharmacological skin treatment.
结果表明，微球主药含量51.74%，体外溶出24小时仅释放30%的药物。氟派酸微球对金黄色葡萄球菌有明显抑制作用。
The results showed that the microcapsule contained 51.74% of basic drug and only 30% of the drug could be released in 24 hours, Norfloxacin showed significant bacteriostatic effect on s, aureus.
结果表明，微球主药含量51.74%，体外溶出24小时仅释放30%的药物。氟派酸微球对金黄色葡萄球菌有明显抑制作用。
The results showed that the microcapsule contained 51.74% of basic drug and only 30% of the drug could be released in 24 hours, Norfloxacin showed significant bacteriostatic effect on s, aureus.
应用推荐